CEACAM5 and neoplasm: Currently, early screening and monitoring of CRC rely on conventional tumor markers including fecal occult blood (FOB), fecal transferrin (TRF), carcinoembryonic antigen (CEA), and carbohydrate antigen 19‐9 (CA19‐9).6, 7, 8